We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$667M
AUM Growth
-$156M
(-19%)
Cap. Flow
+$83.2M
Cap. Flow
% of AUM
12.47%
Top 10 Holdings %
Top 10 Hldgs %
36.65%
Holding
203
New
66
Increased
38
Reduced
28
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
|
+$42.5M |
| 2 |
CELG
Celgene Corp
CELG
|
+$21.6M |
| 3 |
Elevance Health
ELV
|
+$18.4M |
| 4 |
Sunrun
RUN
|
+$13.1M |
| 5 |
Ashland
ASH
|
+$9.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$20.1M |
| 2 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$11.6M |
| 3 |
Macerich
MAC
|
+$11.6M |
| 4 |
NGD
New Gold Inc
NGD
|
+$10.4M |
| 5 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
+$9.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.53% |
| 2 | Miscellaneous | 21.87% |
| 3 | Technology | 20.83% |
| 4 | Utilities | 9.14% |
| 5 | Materials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Darling Ingredients
DAR
$10.3B
| – | – |
-60,000
| Closed | -$1.09M |
|
152
8x8 Inc
EGHT
$266M
| – | – |
-24,000
| Closed | -$338K |
|
153
Exelixis
EXEL
$13.9B
| – | – |
-12,500
| Closed | -$380K |
|
154
Gyre Therapeutics
GYRE
$714M
| – | – |
-2,000
| Closed | -$205K |
|
|
PPLI
155
People Inc
PPLI
$2.79B
| – | – |
-55,954
| Closed | -$1.22M |
|
156
ImmunityBio
IBRX
$8.38B
| – | – |
-25,000
| Closed | -$112K |
|
157
Lumentum
LITE
$83.2B
| – | – |
-84,000
| Closed | -$4.11M |
|
158
Eli Lilly
LLY
$994B
| – | – |
-7,500
| Closed | -$634K |
|
159
Lipocine
LPCN
$18.7M
| – | – |
-588
| Closed | -$34K |
|
|
160
CALL
Macerich
MAC
$6.41B
| – | – |
-200,000
| Closed | -$13.1M |
|
161
McKesson
MCK
$103B
| – | – |
-3,000
| Closed | -$468K |
|
162
Magnite
MGNI
$3.41B
| – | – |
-70,000
| Closed | -$131K |
|
|
NGD
163
DELISTED
New Gold Inc
NGD
| – | – |
-3,700,000
| Closed | -$10.4M |
|
164
NETGEAR
NTGR
$604M
| – | – |
-11,000
| Closed | -$646K |
|
165
PUT
iShares S&P 100 ETF
OEF
$20.4B
| – | – |
-100,000
| Closed | -$12.7M |
|
166
Quanta Services
PWR
$97.8B
| – | – |
-75,000
| Closed | -$2.94M |
|
167
Rapid7
RPD
$695M
| – | – |
-12,000
| Closed | -$224K |
|
|
168
CALL
Sunrun
RUN
$2.06B
| – | – |
-50,000
| Closed | -$295K |
|
|
169
PUT
Sunrun
RUN
$2.06B
| – | – |
-136,800
| Closed | -$807K |
|
170
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
| – | – |
-500,000
| Closed | -$133M |
|
171
Supernus Pharmaceuticals
SUPN
$2.42B
| – | – |
-15,000
| Closed | -$598K |
|
172
Atlassian
TEAM
$45.5B
| – | – |
-7,000
| Closed | -$319K |
|
173
Universal Health Services
UHS
$10.3B
| – | – |
-5,000
| Closed | -$567K |
|
174
Voyager Therapeutics
VYGR
$197M
| – | – |
-25,000
| Closed | -$415K |
|
|
WBA
175
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-5,000
| Closed | -$363K |
|
Similar funds
RAM
JWBC
PL
SCM
LGP
WI
LAM
ACP
Ardsley Advisory Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Ardsley Advisory Partners held 203 positions worth $667M, down 19% from $823M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ardsley Advisory Partners deployed $83.2M of net new capital in Q1 2018, opening 66 new positions and adding to 38 existing holdings. Its largest new stake was Celgene Corp: 224,500 shares worth $20M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Macerich, an estimated $11.6M trimmed.
- Ardsley Advisory Partners's largest Q1 2018 buy was Celgene Corp: 224,500 shares worth $20M.
- Ardsley Advisory Partners added most to ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2018, an estimated $42.5M increase.
- Ardsley Advisory Partners's biggest Q1 2018 reduction was Macerich, cutting an estimated $11.6M.
- Ardsley Advisory Partners fully exited AbbVie in Q1 2018, selling an estimated $20.1M.
- Ardsley Advisory Partners's ten largest holdings make up 37% of its $667M portfolio in Q1 2018.
- Ardsley Advisory Partners opened 66 new positions and closed 61 in Q1 2018.
- Ardsley Advisory Partners's portfolio value fell 19% quarter-over-quarter to $667M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.